BiomX Inc.
PHGE
$0.601
-$0.01-1.64%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 72.24% | 50.79% | 58.27% | 17.94% | 13.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.49% | 35.05% | 72.34% | -2.64% | -5.18% |
| Operating Income | -61.49% | -35.05% | -72.34% | 2.64% | 5.18% |
| Income Before Tax | -164.30% | 222.08% | 169.90% | -172.57% | 6.11% |
| Income Tax Expenses | 200.00% | -- | -37.50% | -16.67% | -97.44% |
| Earnings from Continuing Operations | -164.31% | 221.96% | 169.74% | -172.39% | 6.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -164.31% | 221.96% | 169.74% | -172.39% | 6.71% |
| EBIT | -61.49% | -35.05% | -72.34% | 2.64% | 5.18% |
| EBITDA | -50.06% | -34.70% | -73.07% | 2.84% | 4.70% |
| EPS Basic | 12.01% | 123.73% | 161.46% | -11.94% | 53.95% |
| Normalized Basic EPS | 61.56% | 148.95% | 119.57% | -34.52% | 53.65% |
| EPS Diluted | 2.12% | 123.73% | -47.38% | -11.94% | 53.86% |
| Normalized Diluted EPS | 61.56% | 148.89% | 109.42% | -34.52% | 53.65% |
| Average Basic Shares Outstanding | 200.41% | 170.12% | 40.35% | 93.96% | 102.60% |
| Average Diluted Shares Outstanding | 200.41% | 170.48% | 191.65% | 93.96% | 102.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |